Identifying prodromal disease markers necessitates the use of unbiased population-based study cohorts. In this work, we present the architecture of the data platform we developed for the Healthy Brain Ageing (HeBA) study, a population-based health study co-funded by the Michael J. Fox Foundation (MJFF).
Ghosh et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: